# Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage

> **NCT01836757** · PHASE1 · UNKNOWN · sponsor: **G.Papanikolaou Research Group** · enrollment: 100 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** MethylSulfonylMethane (MSM)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01836757
- **Lead sponsor:** G.Papanikolaou Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836757, "Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01836757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*